Cointime reports: Innovative drug stocks on China’s A-share market fell in volatile trading, with Tonghua Golden-Horse Pharmaceutical hitting the daily limit down. Lummy Pharmaceutical and Innostellar Biotherapeutics dropped more than 10%, while Joinn Laboratories, Chengdu HitGen, GemPharmatech and Shanghai Medicilon each declined more than 6%.
China A-Share Innovative Drug Stocks Fall; Tonghua Golden-Horse Hits Limit Down
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
45m ago
Anthropic Expected to Price IPO Above Range at $80+ Per Share
59m ago
Ark Invest Buys $2.7M of Block Shares as Stock Falls 4.4%
1h ago
Nvidia beats estimates; NVDA perp on Hyperliquid rises 4% to $161.7
2h ago
Anthropic Existing Investors Plan Billions in IPO Share Purchase
3h ago
Analyst: Nvidia’s core business solid, AI infrastructure demand supports guidance
4h ago
SEC Opens Civil Probe Into Nvidia Over Investor Disclosures